This review highlights the involvement of SETDB1 in immune cell development, immune evasion, and innate immune responses within the context of cancer, exploring its dual functions in immune regulation and tumor progression while emphasizing its potential in developing innovative cancer treatments targeting epigenetic dysregulation and oncogenic signaling. Here, SETDB1 is linked to neoplasm.